SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001015402-04-005366
Filing Date
2004-12-13
Accepted
2004-12-10 19:33:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 BIOSANTE SC-13D/A body.htm SC 13D/A 44065
  Complete submission text file 0001015402-04-005366.txt   46322
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filed by) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60689 | Film No.: 041197563
SIC: 2836 Biological Products, (No Diagnostic Substances)